Oscar Health, Inc. (OSCR) vs Tempus AI, Inc. (TEM)
A side-by-side comparison of Oscar Health, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 5, 2026. Differences are shown without an overall score or investment verdict.
OSCR
Oscar Health, Inc.
$30.85HealthcareDelayed quote: Aug 5, 2026, 2:55 PM EDT
TEM
Tempus AI, Inc.
$46.99HealthcareDelayed quote: Aug 5, 2026, 2:55 PM EDT
Total return — OSCR vs TEM
growth of $100 · dividends reinvested · last 2yOSCR +59.9%TEM +16.9%OSCR compounded faster
OSCR TEM
OSCR vs TEM: by the numbers
- •TEM is the larger company ($8.23B vs $8.00B market cap).
- •Both run net losses; OSCR's is the smaller (-0.30% vs -17.77% net margin).
- •OSCR grew revenue faster over the past five years (73.14% vs 38.24% CAGR).
Metrics side by side
Valuation
| Metric | OSCR | TEM |
|---|---|---|
| Forward P/E | 27.53 | N/A |
| P/S ratio | 0.75 | 5.99 |
| P/B ratio | 6.02 | 19.29 |
| EV / EBITDA | 141.85 | N/A |
| FCF yield | 27.93% | N/A |
Profitability
| Metric | OSCR | TEM |
|---|---|---|
| Gross margin | 17.39% | 63.98% |
| Operating margin | 0.08% | -19.76% |
| Net margin | -0.30% | -17.77% |
| ROE | -2.37% | -57.18% |
| ROIC | -27.10% | -10.29% |
Growth (annualized)
| Metric | OSCR | TEM |
|---|---|---|
| Revenue CAGR (5Y) | 73.14% | 38.24% |
| FCF CAGR (5Y) | 46.32% | N/A |
| Total return CAGR (5Y) | 14.78% | N/A |
Frequently asked
- Which has grown faster, OSCR or TEM?
- Over the past five years, OSCR grew revenue faster — OSCR at a 73.14% CAGR versus TEM at 38.24%.
Go deeper
Dig into the metrics
Oscar Health P/E ratioTempus AI P/E ratioOscar Health dividend yieldTempus AI dividend yieldOscar Health ROETempus AI ROEOscar Health operating marginTempus AI operating marginOscar Health revenue growthTempus AI revenue growthOscar Health free cash flowTempus AI free cash flow
Oscar Health & Tempus AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 5, 2026.